Correction: Corrigendum: Long-term,open-labeled extension study of idursulfase in the treatment of Hunter syndrome |
| |
| Affiliation: | 1. Department of Pediatrics University of North Carolina at Chapel Hill Chapel Hill North Carolina;2. Department of Pediatrics University Medical Center, University of Mainz Mainz Germany;3. Baylor College of Medicine Houston Texas;4. Department of Genetics/UFRGSMedical Genetics Service/HCPA and INAGEMP Porto Alegre RS Brazil;5. Department of Gastroenterology and NutritionChildren''s Hospital & Research Center Oakland Oakland California;6. Shire Human Genetic Therapies, Inc.Cambridge Massachusetts;7. Pediatric Metabolic Unit, Cambridge University Teaching Hospitals Cambridge;8. Metabolic Unit, Great Ormond Street Hospital for Children NHS Trust London;9. Willink Biochemical Genetics Unit, Royal Manchester Children''s Hospital Manchester United Kingdom;10. Clinical Research, Genzyme Europe B.V. Naarden The Netherlands;11. Inherited Metabolic Disease Unit, Birmingham Children''s Hospital Birmingham United Kingdom;12. Clinical Development, Novartis Vaccines and Diagnostics Cambridge Massachusetts |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
